Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer

Midazolam can block the development of ovarian cancer, and the relevant mechanism may be realized through the ERK/JNK pathway.

Authors

Institutions

Publication Details

Journal
CytoJournal
Published
2025-11-04
DOI
https://doi.org/10.25259/cytojournal_25_2025
Citations
2
Primary Topic
Cancer, Stress, Anesthesia, and Immune Response
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer

Xiaokun Sun, Bing Fu, Yun Zhang, Haifang Yu
2 citations
CytoJournal
Cancer, Stress, Anesthesia, and Immune Response
2.94
article

Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer

Xiaokun Sun, Bing Fu, Yun Zhang, Haifang Yu
article en
2 citations

Abstract

Midazolam can block the development of ovarian cancer, and the relevant mechanism may be realized through the ERK/JNK pathway.

CytoJournalVol. 22
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN)
Openalex Percentile: Top 8%
Cancer, Stress, Anesthesia, and Immune Response
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer — Xiaokun Sun, Bing Fu, et al. · CytoJournal (2025) | TGRS Research Map | TGRS